ReviewCureus2026
Multivitamins in Adult Medical Practice: Evidence, Risks, and Pragmatic Prescribing.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Use of multivitamin-mineral supplements is common and often occurs outside clinical care. Evidence for broad preventive benefit remains uncertain. We synthesize validated indications, clinical benefits, and harms, and offer a pragmatic prescribing approach for internists. Narrative review of guidelines, randomized trials, and meta-analyses indexed in major databases (2000-August 2025). Priority was given to high-level evidence on hard outcomes (all-cause mortality, cardiovascular events, cancer incidence/mortality, cognition) and to conditions frequently managed in Internal Medicine (malabsorption, bariatric surgery, alcohol use disorder, aging, restrictive diets). This is not a systematic review. Multivitamins are justified for documented deficiencies or high-risk states, including malabsorption, post-bariatric surgery, chronic alcohol use, pregnancy/lactation, and frailty. In generally nourished adults, multivitamins do not reduce cardiovascular events or mortality, and evidence for cancer prevention is marginal without a mortality impact. Recent data suggest small cognitive benefits in older adults. Risks include hypervitaminosis A/D/E, clinically relevant drug-nutrient interactions, masking of specific deficiencies, behavioral displacement of diet-first strategies, and unnecessary cost. Outside of deficiency or clearly increased need, routine multivitamin prescribing provides little clinical gain and exposes patients to avoidable harms. Internists should screen, test, and treat specifically, prefer targeted nutrients, monitor safety, and educate patients against overreliance on supplements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.